Depletion of collagen by losartan to improve tumor accumulation and therapeutic efficacy of photodynamic nanoplatforms


Nanocarriers for drug delivery have made great progress in the treatment of cancer, but the dense extracellular collagen of tumors has greatly limited the efficiency of drug delivery. In this study, losartan is used to deplete tumor collagen and improve the delivery efficiency and photodynamic therapeutic efficacy of chlorine 6 (Ce6)-loaded periodic mesoporous organosilica nanoplatform (Ce6-PMO) for breast cancer. After pretreatment with losartan in vivo, the tumor collagen I fraction is significantly reduced by 53% compared to that of mice pretreated with saline. Importantly, the accumulation of the Ce6-PMO nanoplatforms in the tumor is remarkably enhanced via peritumoral and intravenous injection, respectively, after the mice are pretreated with losartan. Further, combination of losartan with the Ce6-PMO nanoplatforms shows the best therapeutic efficacy, and the suppression rate of tumor volume is measured up to 82%. Taken together, this study provides a very promising synergetic strategy to improve the tumor photodynamic treatment efficacy of nanoplatforms.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6


  1. 1.

    Allison RR. Photodynamic therapy: oncologic horizons. Future Oncol. 2014;10:123–4.

    Article  CAS  PubMed  Google Scholar 

  2. 2.

    Zhang X, Liu T, Li Z, Zhang X. Progress of photodynamic therapy applications in the treatment of musculoskeletal sarcoma (review). Oncol Lett. 2014;8:1403–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Chilakamarthi U, Giribabu L. Photodynamic therapy: past, present and future. Chem Rec. 2017;17:775–802.

    Article  CAS  PubMed  Google Scholar 

  4. 4.

    Fa W, Huang P, Chen X. Overcoming the Achilles’ heel of photodynamic therapy. Chem Soc Rev. 2016;45:6488–519.

    Article  Google Scholar 

  5. 5.

    Benov L. Photodynamic therapy: current status and future directions. Med Princ Pract. 2015;24:14–28.

    Article  PubMed  Google Scholar 

  6. 6.

    Sagnella SM, McCarroll JA, Kavallaris M. Drug delivery: beyond active tumour targeting. Nanomedicine:NBM. 2014;10:1131–7.

    Article  CAS  Google Scholar 

  7. 7.

    Chauhan VP, Stylianopoulos T, BoucherY, Jain RK. Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. Annu Rev Chem Biomol Eng 2011; 2: 281–298.

  8. 8.

    Jain RK. Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. J Clin Oncol. 2013;31:2205–18.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Stylianopoulos T, Martin JD, Chauhan VP, Jain SR, Diop-Frimpong B, Bardeesy N, et al. Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc Natl Acad Sci. 2012;109:15101–8.

    Article  PubMed  Google Scholar 

  10. 10.

    Mckee TD, Grandi P, Mok W, et al. Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector. Cancer Res. 2006;66(5):2509–13.

    Article  CAS  PubMed  Google Scholar 

  11. 11.

    Ganesh S, Edick MG, Idamakanti N, Abramova M, VanRoey M, Robinson M, et al. Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice. Cancer Res. 2007;67:4399–407.

    Article  CAS  PubMed  Google Scholar 

  12. 12.

    Mok W, Boucher Y, Jain RK. Matrix metalloproteinases-1 and -8 improve the distribution and efficacy of an oncolytic virus. Cancer Res. 2007;67:10664–8.

    Article  CAS  PubMed  Google Scholar 

  13. 13.

    Diop-Frimpong B, Chauhan VP, Krane S, Boucher Y, Jain RK. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proc Natl Acad Sci. 2011;108:2909–14.

    Article  PubMed  Google Scholar 

  14. 14.

    Cun X, Ruan S, Chen J, Zhang L, Li J, He Q, et al. A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan. Acta Biomater. 2016;31:186–96.

    Article  CAS  PubMed  Google Scholar 

  15. 15.

    Xiao L, Hu SQ, Wang LY, Liu JX, Li XY. Losartan improves the distribution and efficacy of doxorubicin in CT26 tumor. Eur Rev Med Pharmacol Sci. 2015;19:3763–9.

    CAS  PubMed  Google Scholar 

  16. 16.

    Zhang L, Wang Y, Yang Y, Liu Y, Ruan S, Zhang Q, et al. High tumor penetration of paclitaxel loaded pH sensitive cleavable liposomes by depletion of tumor collagen i in breast cancer. ACS Appl Mater Interfaces. 2015;7:9691–701.

    Article  CAS  PubMed  Google Scholar 

  17. 17.

    Huang P, Chen Y, Lin H, Yu L, Zhang L, Wang L, et al. Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionality. Biomaterials. 2017;125:23–37.

    Article  CAS  PubMed  Google Scholar 

  18. 18.

    Du X, Li X, Xiong L, Zhang X, Kleitz F, Qiao SZ. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery. Biomaterials. 2016;91:90–127.

    Article  CAS  PubMed  Google Scholar 

  19. 19.

    Teng Z, Zhang J, Li W, Zheng Y, Su X, Tang Y, et al. Facile synthesis of yolk-Shell-structured triple-hybridized periodic mesoporous Organosilica nanoparticles for biomedicine. Small. 2016;12:3550–8.

    Article  CAS  PubMed  Google Scholar 

  20. 20.

    Tang Y, Teng Z, Liu Y, Tian Y, Sun J, Wang S, et al. Cytochrome C capped mesoporous silica nanocarriers for pH-sensitive and sustained drug release. J Mater Chem B. 2014;2:4356–62.

    Article  CAS  Google Scholar 

  21. 21.

    Zhang L, Wang Y, Xia T, Yu Q, Zhang Q, Yang Y, et al. Suppression for lung metastasis by depletion of collagen I and lysyl oxidase via losartan assisted with paclitaxel-loaded pH-sensitive liposomes in breast cancer. Drug Deliv. 2016;23(8):2970–9.

    Article  CAS  PubMed  Google Scholar 

  22. 22.

    Grossman M, Ben-Chetrit N, Zhuravlev A, Afik R, Bassat E, Solomonov I, et al. Tumor cell invasion can be blocked by modulators of collagen fibril alignment that control assembly of the extracellular matrix. Cancer Res. 2016;76(14):4249–58.

    Article  CAS  PubMed  Google Scholar 

  23. 23.

    Chauhan VP, Martin JD, Liu H, Lacorre DA, Jain SR, Kozin SV, et al. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat Commun. 2013;4:2516–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Michel MC, Foster C, Brunner HR, Liu L. A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists. Pharmacol Rev. 2013;65:809–48.

    Article  CAS  PubMed  Google Scholar 

Download references


This study received financial support from the National Key Basic Research Program of the PRC (2014CB744501 and 2014CB744504), the National Natural Science Foundation of China (81601555, 81601554, 81501537, and 8140070836).

Author information



Corresponding authors

Correspondence to Shouju Wang or Zhaogang Teng or Guangming Lu.

Ethics declarations

All institutional and national guidelines for the care and use of laboratory animals were followed.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material


(DOCX 199 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tang, Y., Liu, Y., Wang, S. et al. Depletion of collagen by losartan to improve tumor accumulation and therapeutic efficacy of photodynamic nanoplatforms. Drug Deliv. and Transl. Res. 9, 615–624 (2019).

Download citation


  • Losartan
  • Photodynamic therapy
  • Periodic mesoporous organosilica
  • Breast cancer